ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary thera...
ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapy
About this item
Full title
Author / Creator
Bhojwani, D , Pei, D , Sandlund, J T , Jeha, S , Ribeiro, R C , Rubnitz, J E , Raimondi, S C , Shurtleff, S , Onciu, M , Cheng, C , Coustan-Smith, E , Bowman, W P , Howard, S C , Metzger, M L , Inaba, H , Leung, W , Evans, W E , Campana, D , Relling, M V and Pui, C-H
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
ETV6-RUNX1
fusion is the most common genetic aberration in childhood acute lymphoblastic leukemia (ALL). To evaluate whether outcomes for this drug-sensitive leukemia are improved by contemporary risk-directed therapy, we studied clinical features, response and adverse events of 168 children with newly diagnosed
ETV6-RUNX1-
positive ALL on...
Alternative Titles
Full title
ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3345278
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3345278
Other Identifiers
ISSN
0887-6924
E-ISSN
1476-5551
DOI
10.1038/leu.2011.227
